Purchase Order 75F40125P00282

Award Date 9/25/25
Potential Completion Date 10/23/27
Potential Value $81K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Woman-Owned Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
St. Louis, MO 63110, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Food and Drug Administration (FDA) awarded a $780,589.47 firm-fixed-price purchase order contract to Caitta Inc., a certified economically disadvantaged woman-owned small business (EDWOSB), for the procurement of one liquid chromatography-high resolution mass spectrometer (LC-HRMS) system, including a data acquisition computer and software. This contract was set aside for total small business participation and has a performance period ending on February 22, 2027. Caitta Inc. is a...
The U.S. Food and Drug Administration (FDA) awarded a firm-fixed-price purchase order to Caitta Inc., an SBA-certified Economically Disadvantaged Women-Owned Small Business (EDWOSB), for the delivery of a BENCHTOP HYBRID TRIPLE QUADRUPOLE-LINEAR ION TRAP MASS SPECTROMETER. The $309,355.36 contract has an ultimate completion date of September 19, 2025. This contract was set aside for woman-owned small businesses and was awarded under the FDA's $999,000 multiple-award Government Wide Acquisition...
The Food and Drug Administration (FDA) awarded a firm-fixed-price purchase order to Caitta Inc., an SBA-certified economically disadvantaged woman-owned small business (EDWOSB), for the procurement of a Thermo Fisher Vanquish Neo Ultra-High-Performance Liquid Chromatography (UHPLC) system and an Easy-Spray Sources (ESI) kit. The $101,942.76 contract includes installation, testing, training, and warranty support. This award was made under a total small business set-aside solicitation for...
The Department of Health and Human Services' Food and Drug Administration (FDA) awarded a firm fixed-price purchase order contract to Caitta Inc., an SBA-certified economically disadvantaged woman-owned small business (EDWOSB), for a new annual maintenance agreement for a SCIEX QTRAP 5500 LC-MS/MS system. The contract has a ceiling value of $168,262.56 and a completion date of February 19, 2029. Caitta Inc. is an experienced provider of scientific and technical services to federal agencies,...
This is a $535,268.72 firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Caitta Inc., an SBA-certified economically disadvantaged woman-owned small business (EDWOSB). The contract is for the delivery of a quadrupole-orbitrap high resolution mass spectrometer with liquid chromatograph. This specialized scientific instrumentation will support the FDA's analytical and regulatory missions. The contract has an ultimate completion date of October 17, 2026 and...
This federal contract award is for the procurement of a 6500 UPLC-MS MS SYSTEM, a highly specialized scientific instrument, by the Food and Drug Administration (FDA), a civilian government agency. The contract was awarded to Caitta Inc., an SBA-certified economically disadvantaged woman-owned small business (EDWOSB) and 8(a) program participant, through a sole-source set-aside. The fixed-price contract has a ceiling value of $506,179.49 and a completion date of October 16, 2016. Caitta Inc. is a...
The U.S. Food and Drug Administration (FDA) awarded a $1,516,025.52 firm fixed-price purchase order contract to Caitta Inc., an SBA-certified Economically Disadvantaged Women-Owned Small Business (EDWOSB), to provide a Liquid Chromatography Coupled with High Resolution-Accurate Mass Tandem Mass Spectrometer System (LC-HRAM-MS/MS). This contract has a completion date of November 19, 2024 and was set aside for small businesses. Caitta Inc. is an experienced provider of scientific instrumentation...
The U.S. Food and Drug Administration (FDA) awarded a $704,138.55 firm-fixed-price purchase order to Caitta Inc., an SBA-certified Economically Disadvantaged Women-Owned Small Business (EDWOSB), for the procurement of an ultra-high sensitivity, liquid chromatography-hybrid triple quadrupole-linear accelerator trap mass spectrometer (LC-MS/MS) system. This purchase order is set aside for small businesses and has a completion date of September 19, 2027. Caitta Inc. is an experienced federal...
This federal contract award to Caitta Inc., a certified economically disadvantaged woman-owned small business (EDWOSB), is for the procurement of an LC-MS MS triple quad w/ QTRAP capabilities. The $459,234.72 firm fixed price contract was awarded by the Food and Drug Administration (FDA), a civilian agency. The contract has no set-aside designation. Caitta Inc. is a strategic federal contractor that specializes in providing scientific instrumentation, analytical equipment, and professional...
This is a federal purchase order awarded by the Food and Drug Administration (FDA) to Caitta Inc., an SBA-certified economically disadvantaged woman-owned small business (EDWOSB) and 8(a) program participant. The $75,705.31 Firm Fixed Price contract is for the procurement of a liquid handler system, including all parts, software, and equipment. The award is designated as an 8(a) sole source set-aside. Caitta Inc. is a strategic federal contractor that supports the FDA and other civilian agencies...

This federal contract award was made by the Food and Drug Administration (FDA) to Caitta Inc., an SBA-certified economically disadvantaged woman-owned small business (EDWOSB), for the procurement of a Thermo Scientific AutoTrace 280 Solid Phase Extraction (SPE) System or equivalent instrument. The $80,523.76 firm fixed-price purchase order will support the FDA's nitrosamine testing program by automating the pre-concentration of contaminants from large-volume intravenous drug products. The contract has a completion date of October 23, 2027 and was awarded on September 25, 2025 under a woman-owned small business set-aside. Caitta Inc. holds a $2 million Multiple Award Schedule contract with the General Services Administration, which the FDA has utilized to issue a $228,902.70 delivery order for clinical trial site selection services.

Generated 9/26/25, 10:00 AM